Trials in Arkansas.
14 APOE4-relevant Alzheimer’s trials run in Arkansas — 4 of them recruiting. Each one translated into plain English, with our read on what it means for an APOE4 carrier.
- Where
- Little Rock · Fayetteville
- Recruiting
- 4 of 14
Non-carriers only, not for APOE4
Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)This trial tested bapineuzumab, an infused antibody designed to bind and clear beta amyloid from the brain, against a placebo. It measured whether it helped…
CompletedPhase 3NCT00574132Drug trial for diagnosed APOE4 carriers
Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)This trial tested whether bapineuzumab, an antibody given by infusion that helps clear beta amyloid from the brain, could affect thinking and daily function in…
CompletedPhase 3NCT00575055APOE4 enrolled, response may differ
Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's DiseaseThis Phase 3 trial tested rosiglitazone, a diabetes drug, as an add-on to standard Alzheimer's medications like Aricept in people with mild to moderate…
CompletedPhase 3NCT00348140Enrolled carriers, prior data unfavorable
Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's DiseaseThis trial tested whether rosiglitazone extended release, a diabetes drug, could improve thinking and memory in people already taking donepezil for mild to…
CompletedObservationalNCT00348309Drug trial, genotype not specified in source
Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease PatientsThis trial tested bapineuzumab, an antibody drug given by infusion, against a placebo in people with mild to moderate Alzheimer's. It looked at how well the…
TerminatedPhase 3NCT00667810Drug trial, not APOE4-specific, carriers at risk
Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease PatientsThis trial tested bapineuzumab, an antibody drug given by infusion, against a placebo in people with mild to moderate Alzheimer's. Researchers measured safety…
TerminatedPhase 3NCT00676143Drug extension study, prior participants only
A Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease PatientsThis trial looked at the long-term safety and tolerability of bapineuzumab, an antibody drug given by infusion, in people with Alzheimer's who had finished an…
TerminatedPhase 3NCT00998764Open to carriers, not 4-specific
Escitalopram for Agitation in Alzheimer's DiseaseThis Phase 3 trial is testing whether escitalopram, a common antidepressant, can safely reduce agitation in people who already have Alzheimer's dementia. Phase…
ActivePhase 3NCT03108846Not APOE4-related, movement disorder focus
Trial of Parkinson's And Zoledronic AcidThis trial is testing whether a single IV infusion of zoledronic acid, a bone-strengthening drug already approved for osteoporosis, can reduce fractures in…
CompletedPhase 4NCT03924414Open to carriers, not 4-specific
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older AdultsPREVENTABLE is a large Phase 4 trial testing whether atorvastatin 40 mg — a common cholesterol-lowering statin — can reduce the combined risk of death,…
RecruitingPhase 4NCT04262206High ARIA risk for carriers
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)This Phase 3 trial tested donanemab, an anti-amyloid antibody drug, against placebo in people with early Alzheimer's disease. Researchers measured how well it…
ActivePhase 3NCT04437511Non-drug trial, genotype not required
A rTMS and Virtual Reality Based Cognitive Rehabilitation Program for MCIThis trial is testing whether combining brain stimulation (rTMS) with immersive virtual reality cognitive training improves thinking, mood, daily functioning,…
RecruitingObservationalNCT06024473Not aimed at APOE4 carriers
Physical Activity and Community EmPOWERment ProjectThis trial tests PACE, an inclusive physical activity program, for adults with intellectual disability who don't yet show signs of Alzheimer's or related…
RecruitingObservationalNCT06740162Unrelated to APOE4 or Alzheimer's
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's DiseaseThis trial is testing votoplam, an oral drug designed to slow the progression of early-stage Huntington's disease. Researchers are comparing it against a…
RecruitingPhase 3NCT07326709
Copy a forum-ready post
Keep exploring
Educational, not medical advice. Trial decisions belong between you and your physician.